Blockchain Registration Transaction Record

Innovotech Secures $234K from NRC IRAP for Antimicrobial Testing

Innovotech receives up to $234,000 CAD from NRC IRAP to develop new antimicrobial testing services for medical devices like catheters and implants, enhancing safety and regulatory readiness.

This funding enables Innovotech to develop advanced antimicrobial testing for medical devices, directly addressing the global challenge of healthcare-associated infections. By improving testing methods for catheters, implants, and wound dressings, the initiative helps manufacturers meet stricter regulatory standards and deliver safer products. For patients, this means reduced infection risks and better health outcomes. The advancement also strengthens Canada's position in life sciences innovation, offering economic benefits through job creation and enhanced competitiveness in the medical device market.